Informations générales (source: ClinicalTrials.gov)
Adapted Physical Activity in a Chemotherapy Ambulatory Care Unit: Feasibility and Impact on Fatigue, Anxiety and Depression in Cancer Patients (UMACHAPA)
Observational
CHU de Reims (Voir sur ClinicalTrials)
février 2017
février 2018
29 juin 2024
Physical activity has demonstrated efficacy in cancer prevention and improves quality of
life and outcome in cancer survivors. Patients undergoing chemotherapy, especially those
with advanced disease, may have symptoms leading to inactivity. Adapted physical activity
(APA) among those patients could improve their tolerance to the treatment, and thereby
their quality of life. APA could be beneficial to patients with curable disease as well
as patients undergoing palliative chemotherapy. Some studies suggest that fighting
against loss of muscle mass could lead to a survival benefit. However, APA is not
established in daily practice and has not yet been evaluated in a chemotherapy ambulatory
care unit.
Primary aim of the study is to assess feasibility of an APA program in a chemotherapy
ambulatory care unit of digestive, lung, hematological and dermatological cancers
Secondary aim is to measure the impact of an APA program on fatigue, anxiety, depression
and handgrip strength in patients beginning chemotherapy or targeted therapy for a
digestive, lung, hematological or dermatological cancer, of any stage.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Chu de Reims - 51092 - Reims - France | Olivier BOUCHE | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients beginning chemotherapy or targeted therapy at UMA-CH ambulatory care unit
of Reims, CHU, for a digestive, lung, hematological or dermatological cancer, of any
stage
- Patients who agree to participate to the study
- Major patient
- Patients beginning chemotherapy or targeted therapy at UMA-CH ambulatory care unit
of Reims, CHU, for a digestive, lung, hematological or dermatological cancer, of any
stage
- Patients who agree to participate to the study
- Major patient
- Patient with previous chemotherapy or targeted therapy in the UMA-CH unit
- Patient under law protection
- Minor patient
- Patient with neurological defect preventing from any physical activity